CHM 11.1% 2.0¢ chimeric therapeutics limited

Maybe the Lind agreement was dependent on the outcome of the...

  1. 128 Posts.
    lightbulb Created with Sketch. 23
    Maybe the Lind agreement was dependent on the outcome of the SPP. It’s been stated in the quarterlies that other options for funding are being explored.
    You’ve been carrying on about the cash position for a while now and never once acknowledged the broader Marco issues that the bio market in particular is facing. Most small cap bio investors know what they’re getting themselves into.
    Two days ago you said we were going to go into administration and now we have funding and you’ve got issues with that. Sure it might not be ideal but they’ve still managed to raise what they needed and again you ignore the fact that management chipped in a decent amount of that.

    During your due diligence of the company of you ever get around to doing any I suggest you look at the latest small caps interview Jenn did and see how she explains how they managed to get CDH17.

 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.002(11.1%)
Mkt cap ! $17.25M
Open High Low Value Volume
1.9¢ 2.0¢ 1.9¢ $26.18K 1.372M

Buyers (Bids)

No. Vol. Price($)
7 736556 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 1462067 5
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.